Clinical Outcomes of Later‐Generation <scp>EGFR</scp> ‐ <scp>TKIs</scp> for Uncommon <scp>EGFR</scp> Mutations in <scp>NSCLC</scp> : A Multicenter Real‐World Study
Later-generation EGFR-TKIs were associated with improved outcomes in patients with uncommon EGFR mutations, with afatinib showing favorable treatment duration in G719X and compound subtypes.
Authors
- Kohei Horiuchi (ORCID: https://orcid.org/0000-0002-9396-7813)
- Yoshitaka Oyamada (ORCID: https://orcid.org/0000-0002-0035-1316)
- Kenzo Soejima (ORCID: https://orcid.org/0000-0001-9749-995X)
- Shigenari Nukaga (ORCID: https://orcid.org/0000-0003-4136-2879)
- Tetsuo Tani (ORCID: https://orcid.org/0000-0001-5719-2697)
- Shinnosuke Ikemura (ORCID: https://orcid.org/0000-0002-0022-7307)
- Keiko Ohgino (ORCID: https://orcid.org/0000-0002-8280-447X)
- Fumio Sakamaki (ORCID: https://orcid.org/0000-0002-6044-6501)
- Hideki Terai (ORCID: https://orcid.org/0000-0002-1118-1930)
- Taro Shinozaki
- Koichi Fukunaga (ORCID: https://orcid.org/0000-0001-7460-1990)
- Lisa Shigematsu
- Hiroyuki Yasuda (ORCID: https://orcid.org/0000-0001-9966-8569)
- Katsuhiko Naoki (ORCID: https://orcid.org/0000-0002-9637-1388)
- Takashi Sato (ORCID: https://orcid.org/0000-0002-2338-1665)
- Koichi Sayama
Institutions
- Keio University (JP)
- Tokai University Hachioji Hospital (JP)
- Tokyo Medical Center (JP)
- Kawasaki Municipal Hospital (JP)
- Tokyo National Hospital (JP)
- Kitasato University (JP)
- University of Yamanashi (JP)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1111/1759-7714.70179
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Keio University